ALPS Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-26,611
Closed -$546K 976
2018
Q1
$546K Buy
26,611
+4,624
+21% +$94.9K ﹤0.01% 468
2017
Q4
$623K Buy
21,987
+3,673
+20% +$104K ﹤0.01% 372
2017
Q3
$570K Buy
18,314
+5,685
+45% +$177K ﹤0.01% 354
2017
Q2
$400K Buy
+12,629
New +$400K ﹤0.01% 682